|

Tislelizumab, Carboplatin /Cisplatin, Etoposide Clinical Trials

1 actively recruiting trial

Also known as: radiotherapy

Pipeline

Phase 2: 1

Top Sponsors

  • Anhui Provincial Cancer Hospital1

Indications

  • Extensive Stage Small Cell Lung Cancer (ES-SCLC)1
  • Lung Cancer1
  • Cancer1

Other1 trial

Tislelizumab Combined With Chemotherapy and Relayed Radiotherapy in First-line Treatment of ES-SCLC
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.